Niagen Bioscience, Inc. Common Stock
NAGE • NASDAQ
Niagen Bioscience, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Robert N. Fried, with a market cap of $336.3M.
CEORobert N. Fried
Market Cap$336.3M
Next Earnings
Upcoming earnings announcement for Niagen Bioscience, Inc. Common Stock
Date
Wednesday, May 6, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$0.07
Revenue Estimate
$30.1M
Earnings History
Past 12 earnings reports for Niagen Bioscience, Inc. Common Stock
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Q4 2025 | $0.03Est: $0.01 | +200.0% | $33.8MEst: $31.5M | +7.6% | — |
| Nov 4, 2025 | Q3 2025 | $0.05Est: $0.01 | +400.0% | $34.0MEst: $31.2M | +9.0% | — |
| Aug 6, 2025 | Q2 2025 | $0.04Est: $0.01 | +300.0% | $31.1MEst: $28.4M | +9.5% | — |
| May 7, 2025 | Q1 2025 | $0.06Est: $0.02 | +200.0% | $30.5MEst: $27.1M | +12.6% | — |
| Mar 4, 2025 | Q4 2024 | $0.09Est: $0.02 | +350.0% | $29.1MEst: $26.5M | +9.9% | — |
| Oct 31, 2024 | Q3 2024 | $0.02Est: $0.00 | — | $25.6MEst: $23.6M | +8.2% | — |
| Aug 7, 2024 | Q2 2024 | $0.00Est: -$0.02 | +100.0% | $22.7MEst: $23.4M | -3.0% | — |
| May 8, 2024 | Q1 2024 | -$0.01Est: -$0.02 | +50.0% | $22.2MEst: $24.0M | -7.6% | — |
| Mar 6, 2024 | Q4 2023 | $0.00Est: -$0.03 | +100.0% | $21.2MEst: $21.0M | +1.0% | — |
| Nov 8, 2023 | Q3 2023 | -$0.01Est: -$0.03 | +66.7% | $19.5MEst: $20.3M | -3.7% | — |
| Aug 9, 2023 | Q2 2023 | -$0.03Est: -$0.04 | +25.0% | $20.3MEst: $19.2M | +5.9% | — |
| May 10, 2023 | Q1 2023 | -$0.03Est: -$0.05 | +40.0% | $22.6MEst: $19.3M | +16.7% | — |